Journey Medical Corp (DERM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2014 | 12-2013 | 09-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -8,539 | -22,350 | -15,636 | -20,250 |
| Depreciation Amortization | 14 | 20 | 16 | 10 |
| Accounts payable and accrued liabilities | 7 | N/A | -460 | N/A |
| Other Working Capital | 804 | 9,870 | 8,676 | 2,820 |
| Other Operating Activity | 128 | 310 | 666 | 170 |
| Operating Cash Flow | $-7,586 | $-12,150 | $-6,738 | $-17,250 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -8 | -50 | -30 | -30 |
| Investing Cash Flow | $-8 | $-50 | $-30 | $-30 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 2 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 26,470 | 24,499 | 12,060 |
| Financing Cash Flow | $2 | $26,470 | $24,499 | $12,060 |
| Beginning Cash Position | 22,144 | 7,870 | 7,872 | 13,090 |
| End Cash Position | 14,552 | 22,140 | 25,603 | 7,870 |
| Net Cash Flow | $-7,592 | $14,270 | $17,731 | $-5,220 |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,586 | -12,150 | -6,738 | -17,250 |
| Capital Expenditure | -8 | N/A | -30 | N/A |
| Free Cash Flow | -7,594 | -12,150 | -6,768 | -17,250 |